National Institute of Diabetes & Digestive & Kidney Diseases: Bionic Pancreas Improves Type 1 Diabetes Management Compared To Standard Insulin Delivery Methods
September 30, 2022
September 30, 2022
BETHESDA, Maryland, Sept. 30 (TNSjou) -- The Department of Health and Human Services National Institute of Diabetes and Digestive and Kidney Diseases issued the following news release:
A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose (sugar) levels within normal range than standard-of-care management among people with type 1 diabetes, a new multicenter clinical trial has found . . .
A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose (sugar) levels within normal range than standard-of-care management among people with type 1 diabetes, a new multicenter clinical trial has found . . .